BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2076 related articles for article (PubMed ID: 28174608)

  • 1. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
    Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
    Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
    Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
    Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
    Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
    Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
    Fu J; Su Y; Liu Y; Zhang XY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
    [No Abstract]   [Full Text] [Related]  

  • 16. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
    Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
    Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.